PT3558458T - Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca - Google Patents

Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Info

Publication number
PT3558458T
PT3558458T PT178847570T PT17884757T PT3558458T PT 3558458 T PT3558458 T PT 3558458T PT 178847570 T PT178847570 T PT 178847570T PT 17884757 T PT17884757 T PT 17884757T PT 3558458 T PT3558458 T PT 3558458T
Authority
PT
Portugal
Prior art keywords
hydroxybutyrates
glyceryl
symptom management
migraine symptom
migraine
Prior art date
Application number
PT178847570T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of PT3558458T publication Critical patent/PT3558458T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT178847570T 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca PT3558458T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/389,828 US20180177753A1 (en) 2016-12-23 2016-12-23 Glyceryl 3-hydroxybutyrates for migraine symptom management

Publications (1)

Publication Number Publication Date
PT3558458T true PT3558458T (pt) 2023-11-27

Family

ID=62624821

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178847570T PT3558458T (pt) 2016-12-23 2017-11-30 Gliceril 3-hidróxibutiratos para a gestão dos sintomas da enxaqueca

Country Status (13)

Country Link
US (2) US20180177753A1 (cg-RX-API-DMAC7.html)
EP (1) EP3558458B1 (cg-RX-API-DMAC7.html)
JP (1) JP7108320B2 (cg-RX-API-DMAC7.html)
KR (1) KR102390608B1 (cg-RX-API-DMAC7.html)
CN (1) CN110167637B (cg-RX-API-DMAC7.html)
BR (1) BR112019012431A2 (cg-RX-API-DMAC7.html)
CA (1) CA3046350C (cg-RX-API-DMAC7.html)
ES (1) ES2962879T3 (cg-RX-API-DMAC7.html)
IL (1) IL267540B (cg-RX-API-DMAC7.html)
MX (1) MX389468B (cg-RX-API-DMAC7.html)
MY (1) MY190308A (cg-RX-API-DMAC7.html)
PT (1) PT3558458T (cg-RX-API-DMAC7.html)
WO (1) WO2018118369A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
DK3558280T3 (da) 2016-12-21 2023-08-21 Univ Kinderspital Beider Basel Forebyggelse og behandling af migræne
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
EP3880650B1 (de) * 2019-01-17 2023-09-06 KetoLipix Therapeutics GmbH Verfahren zur herstellung von struktureinheiten auf basis von glyceriden von hydroxycarbonsäuren enthaltenden lipiden
CN113329990B (zh) * 2019-01-17 2024-06-07 凯托利皮克斯治疗有限责任公司 羟基羧酸甘油酯的生产方法
BR112021017954A2 (pt) 2019-03-14 2021-11-16 Neuroenergy Ventures Inc Formulação de mascaramento de sabor para compostos de corpo cetônico
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
WO2020242478A1 (en) * 2019-05-30 2020-12-03 Neuroenergy Ventures, Inc. Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks
US20250197566A1 (en) * 2019-06-12 2025-06-19 Ioi Oleo Gmbh Process for preparing polyol-based esters of acyl-capped hydroxy carboxylic acids
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
IT201900018491A1 (it) * 2019-10-10 2021-04-10 Dr Schaer S P A Procedimento di purificazione del tris-(3-idrossibutirrato)-gliceril estere
IT201900018488A1 (it) * 2019-10-10 2021-04-10 Dr Schaer S P A Procedimento di preparazione del tris-(3-idrossibutirrato)-gliceril estere
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
AU2022387742A1 (en) * 2021-11-12 2024-06-27 Arxada Ag Polyol-derived compounds
US20250002446A1 (en) * 2021-11-26 2025-01-02 Arxada Ag Acetoacetate Based Ketals
US20240299548A1 (en) * 2022-01-18 2024-09-12 Today, Inc. Molecules, formulations, and methods for nutritional support of athletes, patients, and others
US12023382B2 (en) 2022-01-18 2024-07-02 Today Inc. Molecules, formulations, and methods for nutritional support of athletes, patients, and others
WO2024083889A1 (en) 2022-10-18 2024-04-25 Arxada Ag Polyol-derived compounds
WO2025074001A2 (en) 2023-10-05 2025-04-10 Arxada Ag Enzymatic reduction of acetoacetate
WO2025196156A1 (en) 2024-03-20 2025-09-25 Arxada Ag Continuous hydrogenation process of acetoacetate esters
WO2025224319A1 (en) 2024-04-25 2025-10-30 Arxada Ag Reduction of acetoacetate esters in the presence of amines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
HUE035852T2 (en) 2006-04-03 2018-05-28 Accera Inc Use of ketogen compounds to treat memory decline
WO2008005818A1 (en) * 2006-06-30 2008-01-10 Stepan Co Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
BRPI1005372A2 (pt) * 2009-01-24 2018-03-06 Phytopharm Plc metodo de indução da homeostase- regulada de fatores neurotroficos agente; composição; e; uso de um ou mais agentes selecionados de saponinas esteroidais de a/b-cis furostano, furosteno espirostano e espirosteno, e as suas formas de eter, cetona e glicosiladas
CA2873057C (en) 2011-05-09 2020-02-25 University Of South Florida The use of ketone esters for prevention of cns oxygen toxicity
US20140072654A1 (en) 2011-12-23 2014-03-13 Savind, Inc. Cancer with metabolic therapy and hyperbaric oxygen
FR2997302B1 (fr) * 2012-10-29 2015-02-06 Assist Publ Hopitaux De Paris Prevention et traitement des deficits en pyruvate deshydrogenase
ES2752030T3 (es) 2012-11-05 2020-04-02 Us Health Cuerpos cetónicos para proteger los tejidos del daño por radiación ionizante
EP2925308B1 (en) 2012-11-28 2019-12-25 University Of South Florida Targeting cancer with metabolic therapy and hyperbaric oxygen
WO2014153416A1 (en) 2013-03-19 2014-09-25 University Of South Florida Compositions and methods for producing elevated and sustained ketosis
GB201314127D0 (en) * 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
EP3549928B1 (en) 2014-01-13 2021-09-22 University of South Florida Methods of sustaining dietary ketosis and its effects on muscle fatigue
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
US9364456B1 (en) 2015-06-30 2016-06-14 University Of South Florida Ketone esters for treatment of angelman syndrome
WO2017011294A1 (en) 2015-07-10 2017-01-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone esters, and other ketogenic sources
US10292952B2 (en) 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US10376482B2 (en) 2016-04-03 2019-08-13 Franco Cavaleri Butyrate and beta-hydroxybutyrate compositions
SG11201809211QA (en) 2016-04-19 2018-11-29 Keto Patent Group Inc Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
WO2018009208A1 (en) 2016-07-08 2018-01-11 Cognate Nutritionals, Inc. Nutritional mitiggation of the cns effects of traumatic brain injury
AU2017322708A1 (en) 2016-09-12 2019-03-21 University Of South Florida Neuroregeneration improved by ketone
DK3558280T3 (da) 2016-12-21 2023-08-21 Univ Kinderspital Beider Basel Forebyggelse og behandling af migræne

Also Published As

Publication number Publication date
CA3046350A1 (en) 2018-06-28
JP7108320B2 (ja) 2022-07-28
BR112019012431A2 (pt) 2020-04-14
EP3558458B1 (en) 2023-10-18
US10792269B2 (en) 2020-10-06
MX2019006844A (es) 2019-08-16
US20180177753A1 (en) 2018-06-28
MY190308A (en) 2022-04-13
IL267540B (en) 2022-07-01
EP3558458A1 (en) 2019-10-30
WO2018118369A1 (en) 2018-06-28
CN110167637A (zh) 2019-08-23
KR102390608B1 (ko) 2022-04-25
CA3046350C (en) 2022-08-16
CN110167637B (zh) 2023-03-14
KR20190099465A (ko) 2019-08-27
EP3558458A4 (en) 2020-08-12
IL267540A (en) 2019-08-29
JP2020502250A (ja) 2020-01-23
ES2962879T3 (es) 2024-03-21
MX389468B (es) 2025-03-20
US20190117612A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
IL267540A (en) Glyceryl 3-hydroxybutyrates for managing migraine symptoms
ZA201605946B (en) Treatments for resistant acne
GB2512545B (en) Update management
GB201401715D0 (en) Exfoliation
GB201415067D0 (en) Authentication management
GB2536880B (en) Memory management
GB2536200B (en) Memory management
GB2537960B (en) Memory management
GB201620954D0 (en) Memory management
GB201820012D0 (en) Stock monitoring
GB2536199B (en) Memory management
GB201400853D0 (en) Emergency access bolt
SG11201702458RA (en) Operation management
GB2529906B (en) Stock Monitoring
AU358772S (en) Stirrup
ZA201509306B (en) Inventory management
SG10201501070UA (en) Elevator-group management system
GB201604125D0 (en) Co-crystal
GB201502124D0 (en) Litter box
GB201900707D0 (en) Stock monitoring
GB201900708D0 (en) Stock monitoring
GB201403437D0 (en) Easy click box
GB2555047B (en) Distribution box
GB2525040B (en) Ear tie
GB201413144D0 (en) Enclosure